Sanofi announced that the FDA has extended the regulatory review of its filing seeking approval to treat non-relapsing secondary progressive MS (nrSPMS) and slow disability accumulation independent of ...

Sanofi’s experimental multiple sclerosis drug got hit with two setbacks on Monday: a regulatory delay in the US as well as a failure in a late-stage clinical trial. The US Food and Drug Administration ...

Sanofi’s experimental drug for multiple sclerosis (MS) has been hit with another US regulatory delay, a setback compounded by disappointing results from a Phase III trial that were announced ...

A Mississippi woman harvested a buck with unusual antlers on her first hunt in six years. The buck appeared unexpectedly during daylight hours on the opening day of gun season. The hunter plans to ...

Malaysian production house Double Vision has formed a strategic alliance with microdrama distributor RisingJoy, marking CEO Min Lim’s company’s entry into the burgeoning short-form content sector.

Contineum Therapeutics’ M1 receptor antagonist has failed to move the needle in a phase 2 vision test for patients with a common form of multiple sclerosis. The Johnson & Johnson-partnered asset, ...

It's a new dawn for MSNBC, which is being rebranded and will now be known as MS NOW. The transition comes as the channel breaks off from its current parent company, Comcast NBCUniversal, and moves to ...

This is read by an automated voice. Please report any issues or inconsistencies here. MSNBC rebrands to MS NOW as NBCUniversal spins the cable network into new company Versant, separating from NBC ...

Courtroom comedy series “Ms. Pat Settles It” finds the comedian and actress presiding over relatable, everyday cases brought forth by real people. To serve as the jury, Ms. Pat enlists an array of ...

After three decades, the MSNBC brand will be retired on Nov. 15. The network has called in Rachel Maddow to help viewers make the transition. By Michael M. Grynbaum Rachel Maddow intoning the preamble ...